WoS
YÖKSİS Eşleşti
2024 Article 22. Yazar
The Efficacy of Glecaprevir/Pibrentasvir in Chronic Hepatitis C Patients and the Impact of the COVID-19 Pandemic: Multicenter Real-Life Data
INFECTIOUS DISEASES AND CLINICAL MICROBIOLOGY
·
Cilt 6, s. 216-224
·
ISSN 2667-646X
Prof. Dr. ŞUA SÜMER
· 26 yazar
WoS
YÖKSİS Eşleşti
2021 Article 7. Yazar
Real-World Data from Turkey: Is Sofosbuvir/Ledipasvir With or Without Ribavirin Treatment for Chronic Hepatitis C Really Effective?
TURKISH JOURNAL OF GASTROENTEROLOGY
·
Cilt 32, s. 155-163
Prof. Dr. ONUR URAL
· 41 yazar
WoS
🏆 JCR Q3 · JIF 0,6
YÖKSİS Eşleşti
2021 Article 2. Yazar
Chronic Hepatitis C in the Pandemic
KLIMIK JOURNAL
·
Cilt 34, s. 13-17
·
ISSN 1301-143X
Prof. Dr. ŞUA SÜMER
· 4 yazar
WoS
YÖKSİS Eşleşti
2020 Article 7. Yazar
Real-world efficacy, safety, and clinical outcomes of ombitasvir/paritaprevir/ritonavir ± dasabuvir ± ribavirin combination therapy in patients with hepatitis C virus genotype 1 or 4 infection: The Turkey experience experience
TURKISH JOURNAL OF GASTROENTEROLOGY
·
Cilt 31, s. 305-317
Prof. Dr. ONUR URAL
· 17 yazar
WoS
🏆 JCR Q1 · JIF 4,5
YÖKSİS Eşleşti
2015 Article 5. Yazar
Retreatment of Chronic Hepatitis C Infection with Telaprevir: Preliminary Results in Turkey
BALKAN MEDICAL JOURNAL
·
Cilt 32, s. 266-272
·
ISSN 2146-3123
WoS
🏆 JCR Q4 · JIF 0,3 2009 Article 1. Yazar
Comparison of the Efficacy of Standard Interferon Alpha 2a Plus Ribavirin and Pegylated Interferon Alpha 2a Plus Ribavirin Combination Therapies in the Treatment of Chronic Hepatitis C Infection
VIRAL HEPATIT DERGISI-VIRAL HEPATITIS JOURNAL
·
Cilt 14, s. 87-90
·
ISSN 1307-9441